Starkman M N, Zelnik T C, Nesse R M, Cameron O G
Arch Intern Med. 1985 Feb;145(2):248-52.
Anxiety has been considered an important clinical feature of patients with pheochromocytomas. We studied 17 patients with active pheochromocytoma to determine whether they experienced anxiety that met criteria of the Diagnostic and Statistical Manual of Mental Disorders, third edition, for either panic disorder or generalized anxiety disorder. Fifty-two patients with primary anxiety disorders were used as a comparison group. Six patients with pheochromocytomas had norepinephrine-secreting tumors and 11 had mixed-secretion tumors, with elevated levels of both epinephrine and norepinephrine. None of the 17 patients described the severe apprehension or fear characteristic of panic attacks and none described agoraphobia. One patient received a diagnosis of possible panic disorder, two met criteria for generalized anxiety disorder, and two met criteria for major depressive episode. Thus, the elevated levels of catecholamines secreted by pheochromocytomas are not sufficient to elicit an anxiety disorder.
焦虑一直被视为嗜铬细胞瘤患者的一项重要临床特征。我们研究了17例活动性嗜铬细胞瘤患者,以确定他们是否经历了符合《精神疾病诊断与统计手册》第三版中惊恐障碍或广泛性焦虑障碍标准的焦虑。52例原发性焦虑症患者作为对照组。17例嗜铬细胞瘤患者中,6例患有分泌去甲肾上腺素的肿瘤,11例患有混合分泌肿瘤,肾上腺素和去甲肾上腺素水平均升高。17例患者中无一例描述过惊恐发作所特有的严重忧虑或恐惧,也无一例描述过广场恐惧症。1例患者被诊断为可能患有惊恐障碍,2例符合广泛性焦虑障碍标准,2例符合重度抑郁发作标准。因此,嗜铬细胞瘤分泌的儿茶酚胺水平升高不足以引发焦虑症。